Translational Development Acquisition TDACW
NASDAQ TDACW
$1.60 -0.25 (-13.51%)
As of: Sep 9, 2026 · 2:59 PM EDT

Translational Development Acquisition (TDACW) Total Debt (2023 - 2026)

Translational Development Acquisition's (TDACW) quarterly Total Debt came in at $1.1 million in Q2 2026, up 120.0% quarter-over-quarter from $500000.0 in Q1 2026.

Analysis

Translational Development Acquisition (TDACW) Total Debt (2023 - 2026) Analysis & Trends

Translational Development Acquisition (TDACW) has reported Total Debt for 3 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Debt changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $200000.0, changed N/A from the prior year.
  • Total Debt climbed to $1.1 million in Q2 2026 per TDACW's latest filing, from $500000.0 in the prior quarter.
  • Across five years, Total Debt topped out at $1.1 million in Q2 2026 and bottomed at $100000.0 in Q3 2025.
  • Historically, Total Debt has averaged $449500.0 across 3 years, with a median of $347500.0 in 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Evercore 11.52 Bn 9.43 Bn 975.67 Mn 539.98 Mn
2 Jefferies Financial 11.24 Bn -4.17 Bn 3.09 Bn 22.75 Bn
3 Houlihan Lokey 9.53 Bn 8.45 Bn - -
4 Cluster Group Holdings 8.00 Bn 8.00 Bn - -
5 PJT Partners 6.94 Bn 6.99 Bn 481.98 Mn -
6 Moelis 6.06 Bn 5.99 Bn - -
7 Piper Sandler Companies 5.20 Bn 5.09 Bn - 30.00 Mn
8 Lazard 4.97 Bn 3.99 Bn - 1.69 Bn
9 BRBI BR Partners 3.44 Bn 3.32 Bn 16.77 Mn 2.33 Bn
10 Translational Development Acquisition 52.67 Mn 52.58 Mn - 1.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Mar 31, 2026 500,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 100,000.00
Dec 31, 2023 347,500.00